The role of hyperbaric oxygen to platelet aggregation in noninsulin-dependent diabetes mellitus (NIDDM). | Canada Hyperbarics Skip to main content
Clinical Study Journal of basic and clinical physiology and pharmacology 2021

The role of hyperbaric oxygen to platelet aggregation in noninsulin-dependent diabetes mellitus (NIDDM).

Widiyanti P, Suryohudoyo P — Journal of basic and clinical physiology and pharmacology, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This study investigated the effect of hyperbaric oxygen (HBO) treatment on platelet aggregation parameters in patients with noninsulin-dependent diabetes mellitus (NIDDM).

What They Found

In 16 NIDDM patients, hyperbaric oxygen treatment significantly decreased platelet aggregation latency time and aggregation index. However, no significant difference was observed in aggregation speed or aggregation percentage after HBO treatment.

Canadian Relevance

This study was conducted in Indonesia and has no direct Canadian connection.

Study Limitations

The study was limited by its small sample size of 16 patients per group and focused on specific platelet parameters rather than broader clinical outcomes.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 34214305
Year Published 2021
Journal Journal of basic and clinical physiology and pharmacology
MeSH Terms Diabetes Mellitus, Type 2; Humans; Hyperbaric Oxygenation; Hyperoxia; Oxygen; Platelet Aggregation

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.